scholarly journals Combined Antiretroviral Treatment Initiation During Hospitalization: Outcomes in South African Adults

2009 ◽  
Vol 51 (1) ◽  
pp. 105-106 ◽  
Author(s):  
Ingrid Eshun-Wilson ◽  
Helen Van der Plas ◽  
Hans W Prozesky ◽  
Michele D Zeier ◽  
Jean Nachega ◽  
...  
2012 ◽  
Vol 16 (11) ◽  
pp. 1510-1516 ◽  
Author(s):  
K. Middelkoop ◽  
L-G. Bekker ◽  
E. Shashkina ◽  
B. Kreiswirth ◽  
R. Wood

2016 ◽  
Vol 145 (1) ◽  
pp. 170-180 ◽  
Author(s):  
R. R. LILIAN ◽  
B. MUTASA ◽  
J. RAILTON ◽  
W. MONGWE ◽  
J. A. McINTYRE ◽  
...  

SUMMARYSouth Africa's paediatric antiretroviral therapy (ART) programme is managed using a monitoring and evaluation tool known as TIER.Net. This electronic system has several advantages over paper-based systems, allowing profiling of the paediatric ART programme over time. We analysed anonymized TIER.Net data for HIV-infected children aged <15 years who had initiated ART in a rural district of South Africa between 2005 and 2014. We performed Kaplan–Meier survival analysis to assess outcomes over time. Records of 5461 children were available for analysis; 3593 (66%) children were retained in care. Losses from the programme were higher in children initiated on treatment in more recent years (P < 0·0001) and in children aged ≤1 year at treatment initiation (P < 0·0001). For children aged <3 years, abacavir was associated with a significantly higher rate of loss from the programme compared to stavudine (hazard ratio 1·9, P < 0·001). Viral load was suppressed in 48–52% of the cohort, with no significant change over the years (P = 0·398). Analysis of TIER.Net data over time provides enhanced insights into the performance of the paediatric ART programme and highlights interventions to improve programme performance.


IDCases ◽  
2020 ◽  
Vol 22 ◽  
pp. e00994
Author(s):  
Andres Quevedo-Ramirez ◽  
Juan Jose Montenegro-Idrogo ◽  
Cristhian Resurrección-Delgado ◽  
Blanca Salazar-Mesones ◽  
Jorge Gallardo-Cartagena ◽  
...  

2005 ◽  
Vol 172 (1) ◽  
pp. 123-127 ◽  
Author(s):  
Catherine Seyler ◽  
Siaka Toure ◽  
Eugène Messou ◽  
Dominique Bonard ◽  
Delphine Gabillard ◽  
...  

2013 ◽  
Vol 18 (4) ◽  
pp. 615-622 ◽  
Author(s):  
Sabine M Hermans ◽  
Yukari C Manabe ◽  
Agnes N Kiragga ◽  
Andy IM Hoepelman ◽  
Joep MA Lange ◽  
...  

2016 ◽  
Vol 13 (1) ◽  
Author(s):  
Jeremy Philip Brown ◽  
Bagrey Ngwira ◽  
Terence Tafatatha ◽  
Amelia Catharine Crampin ◽  
Neil French ◽  
...  

2012 ◽  
Vol 9 (72) ◽  
pp. 1544-1554 ◽  
Author(s):  
Leigh F. Johnson ◽  
Timothy B. Hallett ◽  
Thomas M. Rehle ◽  
Rob E. Dorrington

This study aims to assess trends in human immunodeficiency virus (HIV) incidence in South Africa, and to assess the extent to which prevention and treatment programmes have reduced HIV incidence. Two models of the South African HIV epidemic, the STI (sexually transmitted infection)–HIV Interaction model and the ASSA2003 AIDS and Demographic model, were adapted. Both models were fitted to age-specific HIV prevalence data from antenatal clinic surveys and household surveys, using a Bayesian approach. Both models suggest that HIV incidence in 15–49 year olds declined significantly between the start of 2000 and the start of 2008: by 27 per cent (95% CI: 21–32%) in the STI–HIV model and by 31 per cent (95% CI: 23–39%) in the ASSA2003 model, when expressed as a percentage of incidence rates in 2000. By 2008, the percentage reduction in incidence owing to increased condom use was 37 per cent (95% CI: 34–41%) in the STI–HIV model and 23 per cent (95% CI: 14–34%) in the ASSA2003 model. Both models also estimated a small reduction in incidence owing to antiretroviral treatment by 2008. Increased condom use therefore appears to be the most significant factor explaining the recent South African HIV incidence decline.


Sign in / Sign up

Export Citation Format

Share Document